Shareholding Pattern For June 30, 2015
Cadila Healthcare Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.07-07-2015
07-07-2015
Zydus receives market authorisation for Morphine Sulfate ER Tablets
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated July 01, 2015 titled "Zydus receives market authorisation for Morphine Sulfate ER Tablets".01-07-2015
Zydus receives final approval for Pyridostigmine Bromide Tablets
Cadila Healthcare Ltd has submitted to BSE a copy of Press Release dated June 24, 2015 titled "Zydus receives final approval for Pyridostigmine Bromide Tablets"24-06-2015
Outcome of Board Meeting
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2015, decided to delist Equity Shares of the Company from Ahmedabad Stock Exchange Limited (ASE), in view of non-trading of Equity Shares of the Company on ASE since last so many years.Further, 20,47,48,520 Equity Shares of Rs. 5/- each fully paid-up are listed with BSE Ltd. and National Stock Exchange of India Limited having nationwide...09-06-2015
Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 06, 2015 titled "Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA.".08-06-2015
Investor Presentation
Cadila Healthcare Ltd has submitted to BSE a copy of Investor Presentation May 2015.28-05-2015
Clarifies on News Item
With reference to news item in the Economic Times dated May 21, 2015 regarding "Cadila eyes Claris Arm for Rs. 3400Cr". Cadila Healthcare Ltd has Clarified to BSE as under :"News item in the Economic Times dated May 21, 2015 is a speculative in nature and it is our Company's policy not to respond to any such speculative news items. As a responsible listed Company, we inform stock exchanges of all information which is required to be disclosed,...21-05-2015
Code of Conduct of Fair Disclosure
Cadila Healthcare Ltd has informed BSE regarding Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015.20-05-2015
Result of Postal Ballot
Cadila Healthcare Ltd has informed BSE that the members of the Company have passed the resolutions, by way of Postal Ballot, under Clause 35A.20-05-2015
Clause 20
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a copy of Statement of Appropriation as per Clause 20 of the Listing Agreement for the Financial Year ended March 31, 2015.15-05-2015